CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions - Episode 5

CRESTONE Trial of Seribantumab in NRG1+ Solid Tumors: Real-World Implications

,

Looking toward the future management of NRG1+ solid tumors, expert panelists consider how the availability of seribantumab therapy may impact their practice.